Last $3.83 USD
Change Today -0.02 / -0.52%
Volume 780.3K
SGYP On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 07/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Douglas A. Drossman M.D.

Member of the Scientific Advisory Board, Synergy Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 92 board members in 4 different organizations across 5 different industries.

See Board Relationships
----

Background*

Dr. Douglas A. Drossman, also known as Doug, M.D. served as Scientific and Clinical Advisor of Ocera Therapeutics, Inc. Dr. Drossman is a world authority in the field of functional GI disorders. He is Professor of Medicine and Psychiatry and Co-Director of the UNC Center for Functional GI & Motility Disorders (UNC School of Medicine, Division of Gastroenterology & Hepatology). He serves as Director of Symphony Icon, Inc. Dr. Drossman is a board certified gastroenterologist ...

Read Full Background

Corporate Headquarters*

420 Lexington Avenue
New York, New York 10170

United States

Phone: 212-297-0020
Fax: 212-297-0019

Board Members Memberships*

Director

Education*

Master's Degree
American College of Gastroenterology

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SGYP:US $3.83 USD -0.02

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Peter M. Hecht Ph.D. Co-Founder, Chief Executive Officer and Director
Ironwood Pharmaceuticals, Inc.
$100.0K
Peter S. Greenleaf Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee
Sucampo Pharmaceuticals, Inc.
--
Eduardo Javier Sanchiz Yrazu Chief Executive Officer, Member of Management Board, Chief Executive of Corporate Development & Finance, Executive Director and Member of Compliance Committee
Almirall, S.A.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SYNERGY PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.